Clinical trial
Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy of Phenofibrate Treatment on the Functions of Beta Cells in Children and Adolescents With Newly Diagnosed of Type 1 Diabetes.
NCT05909800 is registered in ClinicalTrials.gov with Medical University of Warsaw as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy of Phenofibrate Treatment on the Functions of Beta Cells in Children and Adolescents With Newly Diagnosed of Type 1 Diabetes.
- Lead sponsor
- Medical University of Warsaw
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 29, 2022
- Completion date
- July 31, 2024
- Enrollment
- 102 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.